Molecular Partners AG
|Category:||Clinical Stage Development Company|
|Time:||15:45 – 16:00|
|Speaker:||Dr. Patrick Amstutz|
Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.